Showing results (1501-1510 of 4,521) with videos related to

Sort By:
Pageof 453
Future Oncology (London, England)|April 1, 2021
Low-dose olanzapine, sedation and chemotherapy-induced nausea and vomiting: a prospective randomized controlled studySandip Mukhopadhyay, Premnath Dutta, Sanatan Banerjee, et al.
Future Oncology (London, England)|March 12, 2015
Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosisCecilia Arana Yi, Constantine S Tam, Srdan Verstovsek
Future Oncology (London, England)|March 12, 2015
Pancreatic neuroendocrine tumors: a reviewKate Young, Ridhima Iyer, Daniel Morganstein, et al.
Future Oncology (London, England)|March 12, 2015
Sorafenib off-target effects predict outcomes in patients treated for hepatocellular carcinomaGiovan Giuseppe Di Costanzo, Giorgio de Stefano, Raffaella Tortora, et al.
Future Oncology (London, England)|April 3, 2015
The investigational proteasome inhibitor ixazomib for the treatment of multiple myelomaPaul G Richardson, Philippe Moreau, Jacob P Laubach, et al.
Future Oncology (London, England)|April 3, 2015
MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumorsGiovanna De Maglio, Mariaelena Casagrande, Michela Guardascione, et al.
Future Oncology (London, England)|August 7, 2020
ENLIVEN study: Pexidartinib for tenosynovial giant cell tumor (TGCT)William Tap
Future Oncology (London, England)|August 9, 2020
FOXD2-AS1 promotes migration and invasion of head and neck squamous cell carcinoma and predicts poor prognosisLi Zhang, Hao Bo, Tingwei Chen, et al.
Future Oncology (London, England)|May 3, 2023
Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myelomaPhilippe Moreau, Niels Wcj van de Donk, Hareth Nahi, et al.
Future Oncology (London, England)|May 23, 2023
Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resectionHoward West, Xiaohan Hu, Diana Chirovsky, et al.
Pageof 453